Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 330

1.

In memoriam: william a. Craig.

Theuretzbacher U, Ambrose PG, MacGowan AP, Andes DR, Sörgel F, Derendorf H, Mouton JW, Drusano GL, Tulkens PM, Dudley MN, Cars O, Nation RL.

Antimicrob Agents Chemother. 2015 Jun;59(6):2971. doi: 10.1128/AAC.00849-15. Epub 2015 Apr 20. No abstract available.

PMID:
25896702
2.

Pharmacokinetic evaluation of avicularin using a model-based development approach.

Buqui GA, Gouvea DR, Sy SK, Voelkner A, Singh RS, da Silva DB, Kimura E, Derendorf H, Lopes NP, Diniz A.

Planta Med. 2015 Apr;81(5):373-81. doi: 10.1055/s-0035-1545728. Epub 2015 Mar 17.

PMID:
25782034
3.

Cavitary Penetration of Levofloxacin among Patients with Multidrug-Resistant Tuberculosis.

Kempker RR, Barth AB, Vashakidze S, Nikolaishvili K, Sabulua I, Tukvadze N, Bablishvili N, Gogishvili S, Singh RS, Guarner J, Derendorf H, Peloquin CA, Blumberg HM.

Antimicrob Agents Chemother. 2015 Jun;59(6):3149-55. doi: 10.1128/AAC.00379-15. Epub 2015 Mar 16.

PMID:
25779583
4.

Pharmacokinetic and pharmacodynamic implications in inhalable antimicrobial therapy.

Mukker JK, Singh RS, Derendorf H.

Adv Drug Deliv Rev. 2015 Mar 11. pii: S0169-409X(15)00021-6. doi: 10.1016/j.addr.2015.03.002. [Epub ahead of print] Review.

PMID:
25770775
5.

Effect of reducing the paediatric stavudine dose by half: a physiologically-based pharmacokinetic model.

Sy SK, Malmberg R, Matsushima A, Asin-Prieto E, Rosenkranz B, Cotton MF, Derendorf H, Innes S.

Int J Antimicrob Agents. 2015 Apr;45(4):413-9. doi: 10.1016/j.ijantimicag.2014.12.016. Epub 2015 Jan 19.

PMID:
25697412
6.

Development and validation of a HPLC-MS/MS method for the determination of phytolaccagenin in rat plasma and application to a pharmacokinetic study.

Wei F, Singh RS, Fueth M, Swarts S, Okunieff P, Derendorf H.

J Pharm Biomed Anal. 2015 Mar 25;107:82-8. doi: 10.1016/j.jpba.2014.12.025. Epub 2014 Dec 22.

PMID:
25575173
7.

Evaluation of in vitro synergy between vertilmicin and ceftazidime against Pseudomonas aeruginosa using a semi-mechanistic pharmacokinetic/pharmacodynamic model.

Zhuang L, Sy SK, Xia H, Singh RP, Mulder MB, Liu C, Derendorf H.

Int J Antimicrob Agents. 2015 Feb;45(2):151-60. doi: 10.1016/j.ijantimicag.2014.09.017. Epub 2014 Nov 1.

PMID:
25465523
8.

Concentration-response studies and modelling of the pharmacodynamics of linezolid: Staphylococcus aureus versus Enterococcus faecium.

Scheerans C, Wicha SG, Michael J, Derendorf H, Kloft C.

Int J Antimicrob Agents. 2015 Jan;45(1):54-60. doi: 10.1016/j.ijantimicag.2014.07.028. Epub 2014 Oct 22.

PMID:
25455852
9.

Enhanced penetration of moxifloxacin into rat prostate tissue evidenced by microdialysis.

K Hurtado F, Laureano JV, de A Lock G, Derendorf H, Dalla Costa T.

Int J Antimicrob Agents. 2014 Oct;44(4):327-33. doi: 10.1016/j.ijantimicag.2014.06.011. Epub 2014 Jul 29.

PMID:
25218157
10.

Measuring drug distribution in the critically ill patient.

Deitchman AN, Derendorf H.

Adv Drug Deliv Rev. 2014 Nov 20;77:22-6. doi: 10.1016/j.addr.2014.08.014. Epub 2014 Sep 3. Review.

PMID:
25194997
11.

Predicting pediatric age-matched weight and body mass index.

Sy SK, Asin-Prieto E, Derendorf H, Samara E.

AAPS J. 2014 Nov;16(6):1372-9. doi: 10.1208/s12248-014-9657-9. Epub 2014 Aug 26.

PMID:
25155824
12.

Pharmacokinetics of para-aminosalicylic acid in HIV-uninfected and HIV-coinfected tuberculosis patients receiving antiretroviral therapy, managed for multidrug-resistant and extensively drug-resistant tuberculosis.

de Kock L, Sy SK, Rosenkranz B, Diacon AH, Prescott K, Hernandez KR, Yu M, Derendorf H, Donald PR.

Antimicrob Agents Chemother. 2014 Oct;58(10):6242-50. doi: 10.1128/AAC.03073-14. Epub 2014 Aug 11.

13.

Relevance of Liver Failure for Anti-Infective Agents: From Pharmacokinetic Alterations to Dosage Adjustments.

Bϋdingen FV, Gonzalez D, Tucker AN, Derendorf H.

Ther Adv Infect Dis. 2014 Feb 1;2(1):17-42.

14.

Population pharmacokinetics of cilengitide in adult and pediatric cancer patients from a nonlinear mixed-effects analysis.

Zühlsdorf M, Bhattaram VA, Campioni M, Krösser S, Derendorf H, Kovar A.

J Clin Pharmacol. 2014 Dec;54(12):1391-9. doi: 10.1002/jcph.343. Epub 2014 Jun 26.

PMID:
24911832
15.

Protein binding of rifapentine and its 25-desacetyl metabolite in patients with pulmonary tuberculosis.

Egelund EF, Weiner M, Singh RP, Prihoda TJ, Gelfond JA, Derendorf H, Mac Kenzie WR, Peloquin CA.

Antimicrob Agents Chemother. 2014 Aug;58(8):4904-10. doi: 10.1128/AAC.01730-13. Epub 2014 May 19.

16.

Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages.

Ikawa K, Kikuchi E, Kikuchi J, Nishimura M, Derendorf H, Morikawa N.

J Clin Pharm Ther. 2014 Aug;39(4):411-7. doi: 10.1111/jcpt.12157. Epub 2014 Mar 24.

PMID:
24661290
17.

Largazole pharmacokinetics in rats by LC-MS/MS.

Yu M, Salvador LA, Sy SK, Tang Y, Singh RS, Chen QY, Liu Y, Hong J, Derendorf H, Luesch H.

Mar Drugs. 2014 Mar 20;12(3):1623-40. doi: 10.3390/md12031623.

18.

Comparison of skin permeability for three diclofenac topical formulations: an in vitro study.

Folzer E, Gonzalez D, Singh R, Derendorf H.

Pharmazie. 2014 Jan;69(1):27-31.

PMID:
24601219
19.

Determination of atypical nonlinear plasma−protein-binding behavior of tigecycline using an in vitro microdialysis technique.

Mukker JK, Singh RP, Derendorf H.

J Pharm Sci. 2014 Mar;103(3):1013-9. doi: 10.1002/jps.23872. Epub 2014 Jan 24.

PMID:
24549736
20.

Clinical development of an advanced intranasal delivery system of azelastine hydrochloride and fluticasone propionate.

Derendorf H, Meltzer EO, Hermann R, Canonica GW.

Drugs Today (Barc). 2014 Jan;50(1):15-31. doi: 10.1358/dot.2014.50.1.2094806.

PMID:
24524103
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk